IDA blend vs Latvia: Cause of death, by non-communicable diseases, ages 60+
IDA blend
69.7%
in 2021
Latvia
83.0%
in 2021
IDA blend rank
28th
Latvia rank
31st
Cause of death, by non-communicable diseases, ages 60+ over time
- IDA blend
- Latvia
How they compare
Latvia currently reports 83.0% against 69.7% in IDA blend, a difference of 13.3%.
That makes Latvia's figure about 1.2 times IDA blend's.
Across all 6 years both countries report, Latvia has been ahead every year.
IDA blend ranks 28th and Latvia ranks 31st of 47 groups.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA blend | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 71.7% | 94.0% | 22.4% | Latvia |
| 2010s | 77.2% | 95.6% | 18.4% | Latvia |
| 2020s | 70.9% | 88.0% | 17.1% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, IDA blend or Latvia?
- Latvia, at 83.0% against 69.7% in IDA blend as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+ between IDA blend and Latvia?
- 13.3%, with Latvia ahead.
- How many years of comparable data are there for IDA blend and Latvia?
- 6 years are reported by both, from 2000 to 2021.
- How do IDA blend and Latvia rank globally for cause of death, by non-communicable diseases, ages 60+?
- IDA blend ranks 28th and Latvia ranks 31st of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+ (% of total deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 60+ due to non-communicable diseases divided by number of all deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.